世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 世界および米国におけるインフルエンザの迅速診断テストの市場規模、現状および予測 2021-2027年Global and United States Rapid Diagnostic Testing for Influenza Market Size, Status and Forecast 2021-2027 インフルエンザ迅速診断テスト（RIDT）は，呼吸器検体中のインフルエンザAおよびBウイルス核タンパク質抗原の存在を識別し，その結果を定性的に（陽性か陰性か）表示することができるイムノアッセイである。米国... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーインフルエンザ迅速診断テスト（RIDT）は，呼吸器検体中のインフルエンザAおよびBウイルス核タンパク質抗原の存在を識別し，その結果を定性的に（陽性か陰性か）表示することができるイムノアッセイである。米国では、数多くのRIDTが市販されている。呼吸器検体におけるインフルエンザウイルス感染の実験室での確認のための基準は、逆転写ポリメラーゼ連鎖反応（RT-PCR）またはウイルス培養である。RIDT は、臨床的に適切な時間枠、すなわち、約 15 分以内に結果を得ることができます。しかし、RIDTは、RT-PCRやウイルス培養に比べて、呼吸器検体中のインフルエンザウイルスを検出する感度が低く、特に地域社会におけるインフルエンザ活動のピーク時には、偽陰性の可能性があるため、RIDT検査の陰性結果は慎重に解釈する必要があります。RIDTの中には、結果の解釈を標準化するために分析装置のリーダーデバイスを使用しているものもある。インフルエンザ迅速診断テスト（RIDT）の分類には、従来型のRIDTとデジタルRIDTがあります。2018年のデジタルRIDTの売上比率は約53.35%です。Rapid Influenza Diagnostic Test (RIDT)は、病院、POCT、その他に応用されています。Rapid Influenza Diagnostic Test (RIDT)のほとんどは病院で使用されており、その市場シェアは2018年で約63.97%となっています。最大の消費地は北米で、2018年の消費市場シェアは約53.65%となっています。北米に続いて2番目に大きな消費地はヨーロッパで、2018年の消費市場シェアは26.27%となっています。 市場競争は激しい。BD、Abbot（Alere）、Quidel、Roche、Thermo Fisher Scientific、Meridian Bioscience、Analytik Jena、Princeton BioMeditech Corporation、BioMerieux、Sekisui Diagnostics、Response Biomedical、SA Scientific、Diazorin（Focus Diagnostics）が業界のリーダーであり、業界で独占的な地位を形成している。 市場分析とインサイト世界のインフルエンザの迅速診断テスト市場 世界のインフルエンザ迅速診断テスト市場規模は、2020年の1億6360万米ドルから2027年には1億6360万米ドルに達すると予測され、2021年から2027年の間、9.0%のCAGRで推移します。 本レポートは、業界標準の正確な分析と高いデータの整合性により、世界のインフルエンザ迅速診断テスト市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界のRapid Diagnostic Testing for Influenza市場全体のサイズも含まれています。 本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のインフルエンザ迅速診断市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のRapid Diagnostic Testing for Influenza市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。 世界のインフルエンザ迅速診断テストの範囲と市場規模 インフルエンザの迅速診断テスト市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のRapid Diagnostic Testing for Influenza市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。 タイプ別セグメント デジタルRIDTs 従来のRIDT アプリケーション別セグメント 病院 POCT その他 地域別 北アメリカ アメリカ カナダ ヨーロッパ ドイツ フランス U.K. イタリア ロシア 北欧 その他のヨーロッパ諸国 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア諸国 ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中近東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他の中東・アフリカ地域 会社別 BD アボット（アレア）社 Quidel ロシュ サーモフィッシャーサイエンティフィック メリディアン・バイオサイエンス アナリティクイエナ プリンストン・バイオメディテック・コーポレーション バイオメリュー 積水化学工業株式会社 レスポンスバイオメディカル SAサイエンティフィック DiaSorin (Focus Diagnostics) ウォンドフォ 北京万泰生物製剤有限公司 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Digital RIDTs 1.2.3 Conventional RIDT 1.3 Market by Application 1.3.1 Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 POCT 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Rapid Diagnostic Testing for Influenza Market Perspective (2016-2027) 2.2 Rapid Diagnostic Testing for Influenza Growth Trends by Regions 2.2.1 Rapid Diagnostic Testing for Influenza Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Rapid Diagnostic Testing for Influenza Historic Market Share by Regions (2016-2021) 2.2.3 Rapid Diagnostic Testing for Influenza Forecasted Market Size by Regions (2022-2027) 2.3 Rapid Diagnostic Testing for Influenza Industry Dynamic 2.3.1 Rapid Diagnostic Testing for Influenza Market Trends 2.3.2 Rapid Diagnostic Testing for Influenza Market Drivers 2.3.3 Rapid Diagnostic Testing for Influenza Market Challenges 2.3.4 Rapid Diagnostic Testing for Influenza Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue 3.1.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue (2016-2021) 3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2016-2021) 3.2 Global Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Rapid Diagnostic Testing for Influenza Revenue 3.4 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio 3.4.1 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Rapid Diagnostic Testing for Influenza Revenue in 2020 3.5 Rapid Diagnostic Testing for Influenza Key Players Head office and Area Served 3.6 Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service 3.7 Date of Enter into Rapid Diagnostic Testing for Influenza Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Rapid Diagnostic Testing for Influenza Breakdown Data by Type 4.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Type (2016-2021) 4.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2022-2027) 5 Rapid Diagnostic Testing for Influenza Breakdown Data by Application 5.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Application (2016-2021) 5.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 6.2 North America Rapid Diagnostic Testing for Influenza Market Size by Type 6.2.1 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 6.2.2 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 6.2.3 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Application 6.3.1 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 6.3.2 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 6.3.3 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 6.4 North America Rapid Diagnostic Testing for Influenza Market Size by Country 6.4.1 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 6.4.2 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 7.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type 7.2.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 7.2.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 7.2.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application 7.3.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 7.3.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 7.3.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 7.4 Europe Rapid Diagnostic Testing for Influenza Market Size by Country 7.4.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 7.4.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 8.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type 8.2.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 8.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application 8.3.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 8.4 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region 8.4.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 9.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type 9.2.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 9.2.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 9.2.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 9.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application 9.3.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 9.3.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 9.3.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 9.4 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country 9.4.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 9.4.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 10.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type 10.2.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 10.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application 10.3.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 10.4 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country 10.4.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BD 11.1.1 BD Company Details 11.1.2 BD Business Overview 11.1.3 BD Rapid Diagnostic Testing for Influenza Introduction 11.1.4 BD Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.1.5 BD Recent Development 11.2 Abbot (Alere) 11.2.1 Abbot (Alere) Company Details 11.2.2 Abbot (Alere) Business Overview 11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Introduction 11.2.4 Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.2.5 Abbot (Alere) Recent Development 11.3 Quidel 11.3.1 Quidel Company Details 11.3.2 Quidel Business Overview 11.3.3 Quidel Rapid Diagnostic Testing for Influenza Introduction 11.3.4 Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.3.5 Quidel Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Rapid Diagnostic Testing for Influenza Introduction 11.4.4 Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Thermo Fisher Scientific 11.5.1 Thermo Fisher Scientific Company Details 11.5.2 Thermo Fisher Scientific Business Overview 11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Introduction 11.5.4 Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.5.5 Thermo Fisher Scientific Recent Development 11.6 Meridian Bioscience 11.6.1 Meridian Bioscience Company Details 11.6.2 Meridian Bioscience Business Overview 11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Introduction 11.6.4 Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.6.5 Meridian Bioscience Recent Development 11.7 Analytik Jena 11.7.1 Analytik Jena Company Details 11.7.2 Analytik Jena Business Overview 11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Introduction 11.7.4 Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.7.5 Analytik Jena Recent Development 11.8 Princeton BioMeditech Corporation 11.8.1 Princeton BioMeditech Corporation Company Details 11.8.2 Princeton BioMeditech Corporation Business Overview 11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Introduction 11.8.4 Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.8.5 Princeton BioMeditech Corporation Recent Development 11.9 BioMerieux 11.9.1 BioMerieux Company Details 11.9.2 BioMerieux Business Overview 11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Introduction 11.9.4 BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.9.5 BioMerieux Recent Development 11.10 Sekisui Diagnostics 11.10.1 Sekisui Diagnostics Company Details 11.10.2 Sekisui Diagnostics Business Overview 11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Introduction 11.10.4 Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.10.5 Sekisui Diagnostics Recent Development 11.11 Response Biomedical 11.11.1 Response Biomedical Company Details 11.11.2 Response Biomedical Business Overview 11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Introduction 11.11.4 Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.11.5 Response Biomedical Recent Development 11.12 SA Scientific 11.12.1 SA Scientific Company Details 11.12.2 SA Scientific Business Overview 11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Introduction 11.12.4 SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.12.5 SA Scientific Recent Development 11.13 DiaSorin (Focus Diagnostics) 11.13.1 DiaSorin (Focus Diagnostics) Company Details 11.13.2 DiaSorin (Focus Diagnostics) Business Overview 11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Introduction 11.13.4 DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.13.5 DiaSorin (Focus Diagnostics) Recent Development 11.14 Wondfo 11.14.1 Wondfo Company Details 11.14.2 Wondfo Business Overview 11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Introduction 11.14.4 Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.14.5 Wondfo Recent Development 11.15 Beijing Wantai Biological Pharmacy 11.15.1 Beijing Wantai Biological Pharmacy Company Details 11.15.2 Beijing Wantai Biological Pharmacy Business Overview 11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Introduction 11.15.4 Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.15.5 Beijing Wantai Biological Pharmacy Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryRapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Rapid Diagnostic Testing for Influenza Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Digital RIDTs 1.2.3 Conventional RIDT 1.3 Market by Application 1.3.1 Global Rapid Diagnostic Testing for Influenza Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 POCT 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Rapid Diagnostic Testing for Influenza Market Perspective (2016-2027) 2.2 Rapid Diagnostic Testing for Influenza Growth Trends by Regions 2.2.1 Rapid Diagnostic Testing for Influenza Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Rapid Diagnostic Testing for Influenza Historic Market Share by Regions (2016-2021) 2.2.3 Rapid Diagnostic Testing for Influenza Forecasted Market Size by Regions (2022-2027) 2.3 Rapid Diagnostic Testing for Influenza Industry Dynamic 2.3.1 Rapid Diagnostic Testing for Influenza Market Trends 2.3.2 Rapid Diagnostic Testing for Influenza Market Drivers 2.3.3 Rapid Diagnostic Testing for Influenza Market Challenges 2.3.4 Rapid Diagnostic Testing for Influenza Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue 3.1.1 Global Top Rapid Diagnostic Testing for Influenza Players by Revenue (2016-2021) 3.1.2 Global Rapid Diagnostic Testing for Influenza Revenue Market Share by Players (2016-2021) 3.2 Global Rapid Diagnostic Testing for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Rapid Diagnostic Testing for Influenza Revenue 3.4 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio 3.4.1 Global Rapid Diagnostic Testing for Influenza Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Rapid Diagnostic Testing for Influenza Revenue in 2020 3.5 Rapid Diagnostic Testing for Influenza Key Players Head office and Area Served 3.6 Key Players Rapid Diagnostic Testing for Influenza Product Solution and Service 3.7 Date of Enter into Rapid Diagnostic Testing for Influenza Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Rapid Diagnostic Testing for Influenza Breakdown Data by Type 4.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Type (2016-2021) 4.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Type (2022-2027) 5 Rapid Diagnostic Testing for Influenza Breakdown Data by Application 5.1 Global Rapid Diagnostic Testing for Influenza Historic Market Size by Application (2016-2021) 5.2 Global Rapid Diagnostic Testing for Influenza Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 6.2 North America Rapid Diagnostic Testing for Influenza Market Size by Type 6.2.1 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 6.2.2 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 6.2.3 North America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 6.3 North America Rapid Diagnostic Testing for Influenza Market Size by Application 6.3.1 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 6.3.2 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 6.3.3 North America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 6.4 North America Rapid Diagnostic Testing for Influenza Market Size by Country 6.4.1 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 6.4.2 North America Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 7.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type 7.2.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 7.2.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 7.2.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 7.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application 7.3.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 7.3.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 7.3.3 Europe Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 7.4 Europe Rapid Diagnostic Testing for Influenza Market Size by Country 7.4.1 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 7.4.2 Europe Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 8.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type 8.2.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 8.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application 8.3.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 8.4 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region 8.4.1 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Rapid Diagnostic Testing for Influenza Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 9.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type 9.2.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 9.2.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 9.2.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 9.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application 9.3.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 9.3.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 9.3.3 Latin America Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 9.4 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country 9.4.1 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 9.4.2 Latin America Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size (2016-2027) 10.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type 10.2.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Type (2016-2027) 10.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application 10.3.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Application (2016-2027) 10.4 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country 10.4.1 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Rapid Diagnostic Testing for Influenza Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BD 11.1.1 BD Company Details 11.1.2 BD Business Overview 11.1.3 BD Rapid Diagnostic Testing for Influenza Introduction 11.1.4 BD Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.1.5 BD Recent Development 11.2 Abbot (Alere) 11.2.1 Abbot (Alere) Company Details 11.2.2 Abbot (Alere) Business Overview 11.2.3 Abbot (Alere) Rapid Diagnostic Testing for Influenza Introduction 11.2.4 Abbot (Alere) Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.2.5 Abbot (Alere) Recent Development 11.3 Quidel 11.3.1 Quidel Company Details 11.3.2 Quidel Business Overview 11.3.3 Quidel Rapid Diagnostic Testing for Influenza Introduction 11.3.4 Quidel Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.3.5 Quidel Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche Rapid Diagnostic Testing for Influenza Introduction 11.4.4 Roche Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Thermo Fisher Scientific 11.5.1 Thermo Fisher Scientific Company Details 11.5.2 Thermo Fisher Scientific Business Overview 11.5.3 Thermo Fisher Scientific Rapid Diagnostic Testing for Influenza Introduction 11.5.4 Thermo Fisher Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.5.5 Thermo Fisher Scientific Recent Development 11.6 Meridian Bioscience 11.6.1 Meridian Bioscience Company Details 11.6.2 Meridian Bioscience Business Overview 11.6.3 Meridian Bioscience Rapid Diagnostic Testing for Influenza Introduction 11.6.4 Meridian Bioscience Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.6.5 Meridian Bioscience Recent Development 11.7 Analytik Jena 11.7.1 Analytik Jena Company Details 11.7.2 Analytik Jena Business Overview 11.7.3 Analytik Jena Rapid Diagnostic Testing for Influenza Introduction 11.7.4 Analytik Jena Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.7.5 Analytik Jena Recent Development 11.8 Princeton BioMeditech Corporation 11.8.1 Princeton BioMeditech Corporation Company Details 11.8.2 Princeton BioMeditech Corporation Business Overview 11.8.3 Princeton BioMeditech Corporation Rapid Diagnostic Testing for Influenza Introduction 11.8.4 Princeton BioMeditech Corporation Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.8.5 Princeton BioMeditech Corporation Recent Development 11.9 BioMerieux 11.9.1 BioMerieux Company Details 11.9.2 BioMerieux Business Overview 11.9.3 BioMerieux Rapid Diagnostic Testing for Influenza Introduction 11.9.4 BioMerieux Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.9.5 BioMerieux Recent Development 11.10 Sekisui Diagnostics 11.10.1 Sekisui Diagnostics Company Details 11.10.2 Sekisui Diagnostics Business Overview 11.10.3 Sekisui Diagnostics Rapid Diagnostic Testing for Influenza Introduction 11.10.4 Sekisui Diagnostics Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.10.5 Sekisui Diagnostics Recent Development 11.11 Response Biomedical 11.11.1 Response Biomedical Company Details 11.11.2 Response Biomedical Business Overview 11.11.3 Response Biomedical Rapid Diagnostic Testing for Influenza Introduction 11.11.4 Response Biomedical Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.11.5 Response Biomedical Recent Development 11.12 SA Scientific 11.12.1 SA Scientific Company Details 11.12.2 SA Scientific Business Overview 11.12.3 SA Scientific Rapid Diagnostic Testing for Influenza Introduction 11.12.4 SA Scientific Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.12.5 SA Scientific Recent Development 11.13 DiaSorin (Focus Diagnostics) 11.13.1 DiaSorin (Focus Diagnostics) Company Details 11.13.2 DiaSorin (Focus Diagnostics) Business Overview 11.13.3 DiaSorin (Focus Diagnostics) Rapid Diagnostic Testing for Influenza Introduction 11.13.4 DiaSorin (Focus Diagnostics) Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.13.5 DiaSorin (Focus Diagnostics) Recent Development 11.14 Wondfo 11.14.1 Wondfo Company Details 11.14.2 Wondfo Business Overview 11.14.3 Wondfo Rapid Diagnostic Testing for Influenza Introduction 11.14.4 Wondfo Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.14.5 Wondfo Recent Development 11.15 Beijing Wantai Biological Pharmacy 11.15.1 Beijing Wantai Biological Pharmacy Company Details 11.15.2 Beijing Wantai Biological Pharmacy Business Overview 11.15.3 Beijing Wantai Biological Pharmacy Rapid Diagnostic Testing for Influenza Introduction 11.15.4 Beijing Wantai Biological Pharmacy Revenue in Rapid Diagnostic Testing for Influenza Business (2016-2021) 11.15.5 Beijing Wantai Biological Pharmacy Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD（diagnostic）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
